considerations for trainers coaching glp-1 therapy Health and Well-Being Adjuvant to Induced Weight Loss Managing Patients on GLP-1 Medications

Active GLP-1 then flows to peripheral organs where it stimulates the incretin effect 1,2,10

Hematology Hematology analyzers are used to count and identify blood cells for the patients

Following high-profile reports in 2024 of an elevated risk of nonarteritic anterior ischemic optic neuropathy (NAION) in type 2 diabetes patients taking glucagonlike peptide-1 (GLP-1) receptor agonists seen at one facility (Massachusetts Eye and Ear), there remains a need to clarify the potential risk of ophthalmic complications from semaglutide exposure using multicenter data

Again its worth reiterating that the potential patient population for these drugs is 42% of the population